Aprea Therapeutics, Inc. (APRE) Form S-3 — Apr 22, 2026
Aprea Therapeutics filed a Form S-3 registration statement to permit the resale of up to 74,349,426 shares of common stock by selling stockholders. The registered shares consist of 37,174,713 shares underlying pre-funded warrants and 37,174,713 shares underlying common warrants issued in a private placement that closed on March 31, 2026. The company will not receive proceeds from the resale of these shares by stockholders, though it will receive cash proceeds from warrant exercises. As of March 31, 2026, the company had 11,982,776 shares of common stock outstanding, meaning the registered shares represent a significant potential increase in the public float.
Key figures
- Offering Price
- 0.9073
- Shares Offered
- 74349426
- Shares Outstanding
- 11982776
- Common Warrants
- 37,174,713
- Prefunded Warrants
- 37,174,713
- Warrant Expiration Date
- December 31, 2029
- Common Warrant Exercise Price
- $0.683
- Prefunded Warrant Exercise Price
- $0.001
Price after filing
Close on the filing date to close N calendar days later (from $0.95). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.